Boundless Bio (BOLD) Accounts Payables (2023 - 2026)
Boundless Bio (BOLD) posted quarterly Accounts Payables of $5.7 million for Q1 2026, up 15.28% year-over-year from $5.0 million in Q1 2025, and down 15.12% quarter-over-quarter from $6.7 million in Q4 2025.
Boundless Bio (BOLD) Accounts Payables (2023 - 2026) Analysis & Trends
Boundless Bio (BOLD) has reported Accounts Payables for 4 consecutive years, with $5.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables rose 15.28% year-over-year to $5.7 million; the TTM figure through Mar 2026 stood at $5.7 million (up 15.28% YoY), while the FY2025 annual figure was $6.7 million, up 25.64% from the prior year.
- Accounts Payables declined to $5.7 million in Q1 2026 per BOLD's latest filing, from $6.7 million in the prior quarter.
- Across five years, Accounts Payables topped out at $8.2 million in Q1 2024 and bottomed at $1.7 million in Q2 2024.
- Historically, Accounts Payables has averaged $5.7 million across 4 years, with a median of $5.8 million in 2025.
- On a YoY basis, Accounts Payables climbed as much as 247.27% in 2025 and fell as far as 39.46% in 2025.
- Boundless Bio's Accounts Payables stood at $4.3 million in 2023, then gained by 25.5% to $5.4 million in 2024, then climbed by 25.64% to $6.7 million in 2025, then slipped by 15.12% to $5.7 million in 2026.
- Business Quant data shows BOLD's Accounts Payables at $5.7 million in Q1 2026, $6.7 million in Q4 2025, and $6.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.84 Bn | 131.99 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.48 Bn | 78.49 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 60.15 Bn | 55.01 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.54 Bn | 10.14 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.22 Bn | 26.38 Bn | - | 35.57 Mn |
| 10 | Boundless Bio | 67.57 Mn | 67.57 Mn | - | 5.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.00 Mn |
| Mar 31, 2026 | 5.71 Mn |
| Dec 31, 2025 | 6.73 Mn |
| Sep 30, 2025 | 6.77 Mn |
| Jun 30, 2025 | 5.86 Mn |
| Mar 31, 2025 | 4.95 Mn |
| Dec 31, 2024 | 5.35 Mn |
| Sep 30, 2024 | 7.04 Mn |
| Jun 30, 2024 | 1.69 Mn |
| Mar 31, 2024 | 8.18 Mn |
| Dec 31, 2023 | 4.27 Mn |